Literature DB >> 15504647

Family disruption, economic hardship and psychological distress in schizophrenia: can they be measured?

M Madianos1, M Economou, O Dafni, E Koukia, A Palli, E Rogakou.   

Abstract

This study examined the dimensions of burden perceived by key-relatives of patients suffering from schizophrenia spectrum disorder by the development of an instrument, the Family Burden Scale (FBS) and the underlying predictors. One hundred and seventy one primary caregivers, living with 158 patients suffering from chronic psychotic illness and maintained on community basis in Athens area, were interviewed by the use of FBS supplemented by the Family Atmosphere Scale and GHQ. Construction procedure and factor analysis of FBS produced a scale of 23 items in four factors, three of them measuring objective and the fourth one, subjective burden. The scale was also proved to be reliable and valid. Forty-five percent of primary caregivers reported high levels of burden. Psychological impairment (high GHQ scores) was related with high levels of burden and negative family atmosphere. Previous admissions and duration of illness were also found to predict burden. The results suggest that FBS differentiates objective from subjective burden. Psychological well being of carers is affected by the dimensions of perceived burden.

Entities:  

Mesh:

Year:  2004        PMID: 15504647     DOI: 10.1016/j.eurpsy.2004.06.028

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  21 in total

1.  Psychiatric rehabilitation in the era of globalization.

Authors:  Michael G Madianos
Journal:  World Psychiatry       Date:  2006-10       Impact factor: 49.548

2.  Burdens and psychological health of family caregivers of people with schizophrenia in two Chinese metropolitan cities: Hong Kong and Guangzhou.

Authors:  Paul Cw Lam; Petrus Ng; Christopher Tori
Journal:  Community Ment Health J       Date:  2013-06-12

3.  The mediating effect of family cohesion in reducing patient symptoms and family distress in a culturally informed family therapy for schizophrenia: A parallel-process latent-growth model.

Authors:  Caitlin A Brown; Amy Weisman de Mamani
Journal:  J Consult Clin Psychol       Date:  2017-11-27

4.  Family burden and functional assessment in the Swedish CLIPS-study: do staff and relatives agree on individuals with psychotic disorders' functional status?

Authors:  Fredrik Hjärthag; Lars Helldin; Anna-Karin Olsson; Torsten Norlander
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02-25       Impact factor: 4.328

5.  The Relationship Between the Perceived Risk of Harm by a Family Member with Mental Illness and the Family Experience.

Authors:  Judith Katz; Deborah Medoff; Li Juan Fang; Lisa B Dixon
Journal:  Community Ment Health J       Date:  2014-12-23

6.  Attitudes toward help-seeking and duration of untreated mental disorders in a sectorized Athens area of Greece.

Authors:  Michael G Madianos; Aphroditi Zartaloudi; George Alevizopoulos; Theofanis Katostaras
Journal:  Community Ment Health J       Date:  2011-05-06

7.  Factors associated with emotional distress among caregivers of patients with schizophrenia in Katsina, Nigeria.

Authors:  Abdulkareem Jika Yusuf; Folorunsho Tajudeen Nuhu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-12       Impact factor: 4.328

8.  Family Functioning in First-Episode and Chronic Psychosis: The Role of Patient's Symptom Severity and Psychosocial Functioning.

Authors:  Katerina Koutra; Sofia Triliva; Theano Roumeliotaki; Maria Basta; Christos Lionis; Alexandros N Vgontzas
Journal:  Community Ment Health J       Date:  2015-08-19

9.  Illness-related components for the family burden of relatives to patients with psychotic illness.

Authors:  Fredrik Hjärthag; Lars Helldin; Ulla Karilampi; Torsten Norlander
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-05-19       Impact factor: 4.328

Review 10.  The burden of schizophrenia on caregivers: a review.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.